Skip to main content
. 2023 May 18;9(5):423. doi: 10.3390/gels9050423

Figure 9.

Figure 9

Sustained release of VEGF promotes COL I (A) and CD 31 (B) expression in bone-surrounding scaffolds 6 and 12 weeks after implantation (n = 3) [44].